Canada Artificial Intelligence In Drug Repurposing Market Size & Outlook
The artificial intelligence in drug repurposing market in Canada is expected to reach a projected revenue of US$ 199.8 million by 2033. A compound annual growth rate of 25.9% is expected of Canada artificial intelligence in drug repurposing market from 2026 to 2033.
Revenue, 2025 (US$M)
$31.7
Estimate, 2026 (US$M)
$39.8
Forecast, 2033 (US$M)
$199.8
CAGR, 2026 - 2033
25.9%
Global Market
Related Markets
Canada artificial intelligence in drug repurposing market highlights
- The Canada artificial intelligence in drug repurposing market generated a revenue of USD 31.7 million in 2025 and is expected to reach USD 199.8 million by 2033.
- The Canada market is expected to grow at a CAGR of 25.9% from 2026 to 2033.
- In terms of segment, software & platform was the largest revenue generating component in 2025.
- Services is the most lucrative component segment registering the fastest growth during the forecast period.
Artificial intelligence in drug repurposing market data book summary
| Market revenue in 2025 | USD 31.7 million |
| Market revenue in 2033 | USD 199.8 million |
| Growth rate | 25.9% (CAGR from 2026 to 2033) |
| Largest segment | Software & platform |
| Fastest growing segment | Services |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software & Platform, Services |
| Key market players worldwide | BostonGene, BenevolentAI, Innophore, BioXcel Therapeutics Inc, Bullfrog AI Holdings Inc, Graphwise, Owkin, Insilico Medicine, Healx |
Other key industry trends
- In terms of revenue, Canada accounted for 2.4% of the global artificial intelligence in drug repurposing market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. artificial intelligence in drug repurposing market is projected to lead the regional market in terms of revenue in 2033.
- Canada is the fastest growing regional market in North America and is projected to reach USD 199.8 million by 2033.
No credit card required*
Publish Date: Apr 01, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Artificial Intelligence In Drug Repurposing Market Scope
Artificial Intelligence In Drug Repurposing Market segmentation & scope
Artificial Intelligence In Drug Repurposing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Insilico Medicine | View profile | 101-250 | Hong Kong, Hong Kong Island, Hong Kong, Asia | www.insilico.com |
| Bullfrog AI Holdings Inc | View profile | 11 | 325 Ellington Boulevard, Unit 317, Gaithersburg, MD, United States, 20878 | www.bullfrogai.com |
| BioXcel Therapeutics Inc | View profile | 74 | 555 Long Wharf Drive, New Haven, CT, United States, 06511 | www.bioxceltherapeutics.com |
| Owkin | View profile | 251-500 | New York, New York, United States, North America | www.owkin.com |
| BostonGene | View profile | 251-500 | Waltham, Massachusetts, United States, North America | www.bostongene.com/ |
| BenevolentAI | View profile | 101-250 | London, England, United Kingdom, Europe | www.benevolent.com |
| Innophore | View profile | 11-50 | Graz, Steiermark, Austria, Europe | innophore.com |
| Graphwise | View profile | 101-250 | New York, New York, United States, North America | graphwise.ai |
| Healx | View profile | 51-100 | Cambridge, Cambridgeshire, United Kingdom, Europe | healx.ai |
Canada Artificial Intelligence In Drug Repurposing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Artificial Intelligence In Drug Repurposing Market Outlook will help companies and investors design strategic landscapes.
Software & Platform was the largest segment with a revenue share of 83.28% in 2025.
Horizon Databook has segmented the Canada artificial intelligence in drug repurposing market based on software & platform, services covering the revenue growth of each sub-segment from 2021 to 2033.
- Canada Artificial Intelligence In Drug Repurposing Market Component Outlook (Revenue, USD Million , 2021-2033)
- Software & Platform
- Services
- Canada Artificial Intelligence In Drug Repurposing Market Application Outlook (Revenue, USD Million , 2021-2033)
- Oncology
- Neurology
- Cardiology
- Infectious Diseases
- Rare & Orphan Diseases
- Other Therapeutic Areas
- Canada Artificial Intelligence In Drug Repurposing Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Machine Learning/Deep Learning
- Natural Language Processing (NLP)
- Knowledge Graphs & Network-Based AI
- Generative AI & Large Language Models (LLMs)
- Computer Vision
- Canada Artificial Intelligence In Drug Repurposing Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutes
- Other End Use
Reasons to subscribe to Artificial Intelligence In Drug Repurposing Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Artificial Intelligence In Drug Repurposing Market Outlook databook
- Our clientele includes a mix of Artificial Intelligence In Drug Repurposing Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada Artificial Intelligence In Drug Repurposing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Canada Artificial Intelligence In Drug Repurposing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Canada Artificial Intelligence In Drug Repurposing Market, 2021-2033 (US$M)
Canada artificial intelligence in drug repurposing market statistics, by component, 2021-2033 (US$M)
